Our results demonstrated that ZOL/IL-2-treated macaques (Group-2) exhibited significantly lower mean CFU counts in lungs than TB drugs only (Group-1), IL-2 plus TB drugs (Group-3) or saline (Group-4) control (p < 0.05 by ANOVA test, Figure 6(A)). This evidence concerns the gene IL2 and tuberculosis.